SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-18-175282
Filing Date
2018-05-25
Accepted
2018-05-25 16:15:45
Documents
11

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ON FORM S-3 d571136ds3.htm S-3 362005
2 EX-1.2B d571136dex12b.htm EX-1.2B 9966
3 EX-4.4 d571136dex44.htm EX-4.4 300470
4 EX-5.1 d571136dex51.htm EX-5.1 27435
5 EX-12.1 d571136dex121.htm EX-12.1 18676
6 EX-23.1 d571136dex231.htm EX-23.1 1972
7 GRAPHIC g571136g03i54.jpg GRAPHIC 5155
8 GRAPHIC g571136g16a63.jpg GRAPHIC 24217
9 GRAPHIC g571136g27v14.jpg GRAPHIC 41199
10 GRAPHIC g571136g41x10.jpg GRAPHIC 3494
11 GRAPHIC g571136g55b23.jpg GRAPHIC 45700
  Complete submission text file 0001193125-18-175282.txt   886895
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Filer) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-225225 | Film No.: 18861721
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1